The authors thank S. Ne Β΄grier, M.D., A. Ravaud, M.D., and G. Chvetzoff for providing the clinical charts of patients included in the external data set.
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation
β Scribed by Jacopo Peccatori; Lisbeth Barkholt; Tanner Demirer; Maria Pia Sormani; Paolo Bruzzi; Fabio Ciceri; Alberto Zambelli; Gian Antonio Da Prada; Paolo Pedrazzoli; Salvatore Siena; Gero Massenkeil; Rodrigo Martino; Stig Lenhoff; Paolo Corradini; Giovanni Rosti; Olle Ringden; Marco Bregni; Dietger Niederwieser
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 76 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In this uniβcentre retrospective study, we studied 120 adults with acute myeloid leukaemia (AML) (__n__β=β88) and myelodysplastic syndrome (MDS) (__n__β=β32) who received first allogeneic HSCT to determine prognostic factors which are correlated with the outcome after myeloablative (MA)
## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a leading cause of death in patients with leukemia and those who have undergone hematopoietic stem cell transplantation. Laboratory studies have demonstrated that iron is essential for __Aspergillus__ growth and virulence. ## METHODS. In